Compare AVXL & VFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVXL | VFF |
|---|---|---|
| Founded | 2004 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.2M | 230.2M |
| IPO Year | 2013 | 2013 |
| Metric | AVXL | VFF |
|---|---|---|
| Price | $3.15 | $1.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $22.00 | N/A |
| AVG Volume (30 Days) | ★ 958.2K | 690.8K |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 184.38 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $215,937,000.00 |
| Revenue This Year | N/A | $12.19 |
| Revenue Next Year | N/A | $15.82 |
| P/E Ratio | ★ N/A | $97.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.26 | $1.61 |
| 52 Week High | $11.70 | $4.99 |
| Indicator | AVXL | VFF |
|---|---|---|
| Relative Strength Index (RSI) | 64.89 | N/A |
| Support Level | $2.93 | N/A |
| Resistance Level | $3.07 | N/A |
| Average True Range (ATR) | 0.14 | 0.00 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 100.00 | 0.00 |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Cannabis - Netherlands. The company makes majority of its revenue from the Cannabis Canada segment.